Navigation Links
Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
Date:5/6/2013

DURHAM, N.C., May 6, 2013 /PRNewswire-iReach/ -- Health Decisions, Inc., the leader in improving clinical trial efficiency, today announced that Business Leader Magazine named CEO Michael Rosenberg , MD, MPH one of its 2013 Top Entrepreneurs in the Triangle area of North Carolina, one of the leading biotechnology hubs in the United States. Dr. Rosenberg was honored at an awards dinner April 25 at the Brier Creek Country Club in Raleigh, NC.

(Photo: http://photos.prnewswire.com/prnh/20130506/CG07227)

"Business Leader once again is thrilled to present these very special awards to honor and recognize the Triangle's leading entrepreneurs," said Stephen Reynolds , publisher of Business Leader. "The Triangle has such a strong, successful and diverse entrepreneurial community. Whether serving those in need or working on breakthrough innovations in health care, these winners are changing people's lives. We thank each of our finalists for years of hard work and passion to make a difference."

"I'm honored to be recognized by Business Leader following an outstanding year at Health Decisions," Dr. Rosenberg said. "Health Decisions extended its leadership in clinical research in areas such as adaptive monitoring, where our proprietary solution enables us to reduce cost and improve data quality simultaneously. Entrepreneurial spirit throughout our company drives the innovation that allows us to conduct large trials with market-leading efficiency. A 12,000-patient study of a colorectal cancer diagnostic and a 3,500-patient global contraceptive study are recent examples."

Each year since 1996, Business Leader
'/>"/>

SOURCE Health Decisions
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... September 01, 2014 Available spectra ... needs for research and cultivation of a wide ... Valoya’s proprietary LEDs with proven patented and pending ... uncompromised light uniformity in critical applications in contrast ... LEDs. , “Our customers have a large variety ...
(Date:8/29/2014)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... and difficult to manufacture proteins including biosimilar therapeutics, ... results for the second quarter ended June 30, ... our initial public offering, we have the capital ... derived from our proprietary protein expression platform," stated ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 Pittcon ... Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have ... on September 5, 2014. JASIS , Asia’s largest ... 3-5, 2014, in Makuhari Messe, Japan. , The ... Tools for Bioanalysis from Single Molecules to Single Cells” ...
(Date:8/29/2014)... Due to a misstatement posted by the ... Stem Cell Technology Center, LLC ( ASCTC ) was reported ... research that might benefit ALS patients. Because of ASCTC's ... cell technologies and therapeutic applications, FRC listed ASCTC as one ... donors who wish not to support research that requires the ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... Despite a number of key issues such as land use ... uses, global use of biofuels is excepted to more than ... analysis released today by Hart,s Global Biofuels Center. Leading the ... biofuels use of more than 35%. Brazil will grow domestic ...
... , DURHAM, N.C., Sept. 29 Oxygen Biotherapeutics, ... a new presentation for investors by company chairman ... the company website. The link to the presentation ... the Investor Relations section of the website at ...
... ANN ARBOR, Mich.---University of Michigan physicists have created ... major step toward the goal of producing "designer ... Quantum dots---often called artificial atoms or nanoparticles---are ... computing, photovoltaic cells, light-emitting devices and other technologies. ...
Cached Biology Technology:Global Biofuels Growth to Double by 2015 2Global Biofuels Growth to Double by 2015 3Global Biofuels Growth to Double by 2015 4U-M physicists create first atomic-scale map of quantum dots 2
(Date:8/29/2014)... at UC Davis have made some surprising discoveries ... Studying simian immunodeficiency virus (SIV), the team found ... cells are early responders to viral invasion and ... a cytokine called interleukin-1 beta (IL-1β). , ... causes breakdown of the gut epithelium that provides ...
(Date:8/29/2014)... researcher from the University of Texas Medical Branch at Galveston ... monoclonal antibodies can completely protect monkeys against a lethal dose ... a time when the disease is severe. , Thomas Geisbert, ... Nature discussing advances in Ebola treatment research. The ... the most deadly of pathogens, with fatality rates of up ...
(Date:8/29/2014)... news release is available in German . ... key players in the natural nitrogen cycle on Earth ... specialist bacteria were thought to depend on nitrite as ... led by Holger Daims, a microbiologist at the University ... use hydrogen as an alternative source of energy. The ...
Breaking Biology News(10 mins):The early cost of HIV 2Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3
... our bones undergo remodeling every day of our lives, as ... form. In diseases such as osteoporosis, an imbalance in this ... at the Weizmann Institute of Science, which recently appeared in ... how the roving cells whose job is to digest bone ...
... lung cancer with "moderate accuracy" even in the early stages, ... could revolutionise the way cancer is detected and potentially save ... chemical colour sensor, which detects tiny changes in the unique ... , Metabolic changes in lung cancer cells cause changes ...
... report that freezing kidney tumors through percutaneous cryoablation shows ... surgery. Their early findings showing short-term success in ... in this month’s issue of Radiology. , The standard ... likelihood of a long-term cure. For some patients, ...
Cached Biology News:Ring-around-the-cell 2Cryoablation -- A new treatment option for some kidney tumor patients 2Cryoablation -- A new treatment option for some kidney tumor patients 3
Rabbit anti-phospho-EGFr (Tyr992) - Concentrate...
CMRL Medium-1066 (1X) liquid...
... (PEBP) does not share significant homology ... PEBP is expressed in the central ... and stomach. One important role ... inhibitory activity against several serine proteases ...
karyopherin alpha2 (2G7)...
Biology Products: